Novartis AG to buy immunology specialist Calypso Biotech BV
<a title="http://www.b3cnewswire.com/PRT/link.php?click=1630-2-24167-8B20BDBA70E6BDF1B5F7FEECBC3EA611CB7D4F450000" target="_blank" rel="nofollow noopener" href="http://www.b3cnewswire.com/PRT/link.php?click=1630-2-24167-8B20BDBA70E6BDF1B5F7FEECBC3EA611CB7D4F450000">Calypso Biotech BV</a> has entered into an agreement to be acquired by Novartis AG, which will pay. Calypso’s US$250m upfront upon closing plus of up […]